BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song XL, Ju RJ, Xiao Y, Wang X, Liu S, Fu M, Liu JJ, Gu LY, Li XT, Cheng L. Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer. Int J Nanomedicine 2017;12:7433-51. [PMID: 29066893 DOI: 10.2147/IJN.S141787] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Radhakrishnan D, Mohanan S, Choi G, Choy J, Tiburcius S, Trinh HT, Bolan S, Verrills N, Tanwar P, Karakoti A, Vinu A. The emergence of nanoporous materials in lung cancer therapy. Science and Technology of Advanced Materials. [DOI: 10.1080/14686996.2022.2052181] [Reference Citation Analysis]
2 Aydin O, Passaro AP, Raman R, Spellicy SE, Weinberg RP, Kamm RD, Sample M, Truskey GA, Zartman J, Dar RD, Palacios S, Wang J, Tordoff J, Montserrat N, Bashir R, Saif MTA, Weiss R. Principles for the design of multicellular engineered living systems. APL Bioengineering 2022;6:010903. [DOI: 10.1063/5.0076635] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Qiong L, Yin J. Orosomucoid 1 promotes epirubicin resistance in breast cancer by upregulating the expression of matrix metalloproteinases 2 and 9. Bioengineered 2021;12:8822-32. [PMID: 34654351 DOI: 10.1080/21655979.2021.1987067] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Kumar K, Chawla R. Nanocarriers-mediated therapeutics as a promising approach for treatment and diagnosis of lung cancer. Journal of Drug Delivery Science and Technology 2021;65:102677. [DOI: 10.1016/j.jddst.2021.102677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Rawal S, Patel M. Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers. Nanomicro Lett 2021;13:142. [PMID: 34138386 DOI: 10.1007/s40820-021-00630-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Abawi A, Wang X, Bompard J, Bérot A, Andretto V, Gudimard L, Devillard C, Petiot E, Joseph B, Lollo G, Granjon T, Girard-Egrot A, Maniti O. Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines. Int J Mol Sci 2021;22:4103. [PMID: 33921088 DOI: 10.3390/ijms22084103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Sabir F, Qindeel M, Zeeshan M, Ul Ain Q, Rahdar A, Barani M, González E, Aboudzadeh MA. Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review. Processes 2021;9:621. [DOI: 10.3390/pr9040621] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
8 Ștefan G, Hosu O, De Wael K, Lobo-castañón MJ, Cristea C. Aptamers in biomedicine: Selection strategies and recent advances. Electrochimica Acta 2021;376:137994. [DOI: 10.1016/j.electacta.2021.137994] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
9 Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer 2021;20:7. [PMID: 33397409 DOI: 10.1186/s12943-020-01288-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 49] [Article Influence: 10.0] [Reference Citation Analysis]
10 Majumder J, Minko T. Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus. Adv Ther (Weinh) 2020;:2000203. [PMID: 33173809 DOI: 10.1002/adtp.202000203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Sharma N, Kumari RM, Gupta N, Syed A, Bahkali AH, Nimesh S. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells. Molecules 2020;25:E4243. [PMID: 32947799 DOI: 10.3390/molecules25184243] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
12 Tang K, Zhang Y, Chen L, Qu Z. [Effect of honokiol on proliferation, migration and apoptosis of human tongue cancer CAL-27 cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:580-5. [PMID: 32895138 DOI: 10.12122/j.issn.1673-4254.2020.04.21] [Reference Citation Analysis]
13 Parvathaneni V, Kulkarni NS, Shukla SK, Farrales PT, Kunda NK, Muth A, Gupta V. Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment. Pharmaceutics 2020;12:E206. [PMID: 32121070 DOI: 10.3390/pharmaceutics12030206] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 10.5] [Reference Citation Analysis]
14 Kong L, Cai FY, Yao XM, Jing M, Fu M, Liu JJ, He SY, Zhang L, Liu XZ, Ju RJ, Li XT. RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply. Cancer Sci 2020;111:621-36. [PMID: 31777993 DOI: 10.1111/cas.14256] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
15 Kullberg M, Francian A, Arabi A, Olsson T, Mann K, Martinson HA. Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer. Pharm Front 2019;1:e190007. [PMID: 31886474 DOI: 10.20900/pf20190007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Lujan H, Griffin WC, Taube JH, Sayes CM. Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells. Int J Nanomedicine 2019;14:5159-73. [PMID: 31371954 DOI: 10.2147/IJN.S203330] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
17 Wang Y, Fu M, Liu J, Yang Y, Yu Y, Li J, Pan W, Fan L, Li G, Li X, Wang X. Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer. Int J Nanomedicine 2019;14:4071-90. [PMID: 31239668 DOI: 10.2147/IJN.S194304] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
18 Mukherjee A, Paul M, Mukherjee S. Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer. Cancers (Basel) 2019;11:E597. [PMID: 31035440 DOI: 10.3390/cancers11050597] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 13.3] [Reference Citation Analysis]